Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis

Gastroenterology
K D Fine, E L Lee

Abstract

The pathogenesis of the microscopic colitis syndrome is unknown but may involve bacteria, an intestinal luminal antigen, and/or autoimmunity. It was hypothesized that bismuth subsalicylate would resolve both diarrhea and colonic inflammation in microscopic colitis because it possesses antidiarrheal, antibacterial, and anti-inflammatory properties. Thirteen patients with microscopic colitis (7 with subepithelial collagen deposition and 6 without) were treated with eight chewable 262-mg bismuth subsalicylate tablets per day for 8 weeks. Patients recorded the frequency of bowel movements daily. Forty-eight-hour stool collections and flexible sigmoidoscopy with 24 biopsies were performed before and after treatment in each patient. Twelve patients completed the trial. Eleven patients had a resolution of diarrhea and a reduction in fecal weight. The average time to respond was 2 weeks. In 9 patients, colitis resolved. When present before treatment, subepithelial collagen thickening disappeared. Those completing the trial experienced no side effects. Posttreatment follow-up for 7-28 months shows that 9 patients remain well having undergone no further treatment, 2 are well but required retreatment, and 1 has continued diarrhea. Bismuth...Continue Reading

References

Apr 1, 1976·The Journal of Clinical Investigation·R K FarrisS M Morris
May 1, 1991·Journal of Internal Medicine·H SlothA Grove
Jan 15, 1990·Annals of Internal Medicine·P C MendelowitzS Weber
Jan 1, 1990·Reviews of Infectious Diseases·J D Gryboski, S Kocoshis
Jan 1, 1990·Reviews of Infectious Diseases·M D Manhart
Jan 1, 1990·Reviews of Infectious Diseases·D W Bierer
Jan 18, 1980·JAMA : the Journal of the American Medical Association·H L DuPontW S Tjoa
Jun 10, 1993·The New England Journal of Medicine·D Figueroa-QuintanillaE Eyzaguirre-Maccan
Aug 1, 1996·Alimentary Pharmacology & Therapeutics·L A TillmanJ R Wood

❮ Previous
Next ❯

Citations

Jan 9, 2007·Inflammatory Bowel Diseases·David LimsuiWilliam J Sandborn
Jan 24, 2007·International Journal of Colorectal Disease·Alberto Rubio-TapiaMisael Uribe
Jul 21, 2011·Current Gastroenterology Reports·Eugene F Yen, Darrell S Pardi
Nov 30, 2000·Current Treatment Options in Gastroenterology·M Cruz-Correa, F M Giardiello
Jun 6, 2007·Current Treatment Options in Gastroenterology·John R Stroehlein
Nov 30, 2000·Current Treatment Options in Gastroenterology·J K Marshall, E J Irvine
Feb 7, 2013·Best Practice & Research. Clinical Gastroenterology·Zhongzhen Li, Haleh Vaziri
Feb 7, 2013·Best Practice & Research. Clinical Gastroenterology·Eugene F Yen, Darrell S Pardi
May 23, 2003·Gastroenterology·Robin C Spiller
Jun 18, 1999·Gastroenterology Clinics of North America·F M Giardiello, A J Lazenby
Mar 16, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Michael Camilleri
Sep 5, 2012·Nature Reviews. Gastroenterology & Hepatology·Stacy MeneesWilliam D Chey
Dec 14, 1999·The British Journal of Surgery·R C JohnsonM K Crumplin
May 2, 2002·Journal of Gastroenterology and Hepatology·Peter TagkalidisPeter Gibson
Nov 1, 2002·The American Journal of Surgical Pathology·Heidi SappRobert D Odze
Oct 13, 2006·Current Opinion in Gastroenterology·M Cruz-CorreaT M Bayless
Feb 11, 2005·Current Opinion in Gastroenterology·John R Stroehlein
Apr 4, 2000·Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates·P Trolli
Apr 25, 2000·Journal of Clinical Gastroenterology·W J Tremaine
Sep 26, 2003·Journal of Pediatric Gastroenterology and Nutrition·C CamareroG Roy
Jan 1, 2005·Inflammatory Bowel Diseases·Darrell S Pardi
Apr 30, 2004·Journal of Clinical Gastroenterology·Lawrence R Schiller
Nov 30, 2011·Current Opinion in Gastroenterology·Darrell S Pardi
May 18, 2006·Journal of Gastroenterology and Hepatology·Łukasz LiszkaJacek Pajak
Jul 18, 2000·Gut·W E Roediger, W J Babidge
Mar 22, 2013·Clinical and Experimental Gastroenterology·Sony S ThazhathTimothy H Florin
Nov 28, 2012·World Journal of Gastroenterology : WJG·Gianluca IaniroAntonio Gasbarrini
Jan 13, 2010·Age and Ageing·Jennifer J WilliamsMartin A Storr
Nov 20, 2002·European Journal of Gastroenterology & Hepatology·Paul A KitchenUNKNOWN London Inflammatory Bowel Disease Forum
Oct 17, 2015·Expert Review of Gastroenterology & Hepatology·Aranzazu Jauregui-AmezagaKarel Geboes
Nov 26, 2013·Clinics in Geriatric Medicine·Darrell S Pardi
Aug 25, 2012·Gastroenterology Clinics of North America·Heimo H Wenzl
Aug 25, 2012·Gastroenterology Clinics of North America·Jan Tack
Dec 17, 2011·Biochemical Pharmacology·Suzana KovacGraham S Baldwin
Feb 10, 2011·Gastroenterology·Darrell S Pardi, Ciarán P Kelly
Jul 28, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Peter H R GreenGovind Bhagat
May 15, 2003·Mayo Clinic Proceedings·Darrell S Pardi
May 8, 2008·Læknablađiđ·Olafur A SveinssonJon Gunnlaugur Jonasson
Mar 21, 2006·Gastrointestinal Endoscopy Clinics of North America·Sunanda Kane
Feb 24, 2007·Pharmacotherapy·Geoffrey C WallMichael J Page
Feb 20, 2013·Journal of Digestive Diseases·William R Brown, Shalini Tayal
May 7, 2011·Alimentary Pharmacology & Therapeutics·E F Yen, D S Pardi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.